Dual versus single antiplatelet therapy in patients with non-cardioembolic acute ischemic stroke and baseline MRI
We found no evidence of major treatment effect heterogeneity with DAPT compared with SAPT in patients with and without LAA or by stroke size on MR-DWI.
Authors
- Eric Edward Smith (ORCID: https://orcid.org/0000-0003-3956-1668)
- Pablo C. Colorado (ORCID: https://orcid.org/0009-0005-4228-7366)
- Hardi Mundl (ORCID: https://orcid.org/0000-0001-6218-3058)
- Ashkan Shoamanesh (ORCID: https://orcid.org/0000-0002-2802-1626)
- Tolga Dittrich (ORCID: https://orcid.org/0000-0002-9987-3631)
- Gian Marco De Marchis (ORCID: https://orcid.org/0000-0002-0342-9780)
- Dimitrios Vlachos (ORCID: https://orcid.org/0000-0002-0430-2386)
- Robert G. Hart (ORCID: https://orcid.org/0000-0002-3210-167X)
- Anna Toebak
- Angela Wang
Institutions
- Bayer (United States) (US)
- University of Calgary (CA)
- University of Basel (CH)
- University of St.Gallen (CH)
- Population Health Research Institute (CA)
- Department of Biomedicine Basel (CH)
- Bayer (Germany) (DE)
- McMaster University (CA)
Publication Details
- Journal
- European Stroke Journal
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1177/23969873251323180
- Citations
- 2
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 2.71